Renaissance Capital logo

Estrella Biopharma (TradeUP Acquisition) Priced, Nasdaq: ESLA

Blank check company targeting technology businesses operating in various sectors (completed 9/29/2023).

Industry: SPAC

Latest Trade: $1.02 0.00 (0.0%)

First Day Return: -0.4%

Return from IPO: -89.8%

Industry: SPAC

We are a newly organized blank check company. One of our founders is our sponsor, TradeUP Acquisition Sponsor LLC, whose members are our Co-Chief Executive Officers. Our business strategy is to identify and complete our initial business combination with a technology company preferable with operations in the automotive or automotive-related, semiconductor, artificial intelligence, digital health, e-commerce and education sectors. We expect to leverage our management team’s relationships with corporate executives, venture capitalists, entrepreneurs and private equity firms. We believe that our deal sourcing network will provide us with a pipeline of suitable potential targets. In combination of our management team’s relationships and domain expertise, we look to execute a business combination that increases shareholder value. We represent a diverse combination of sourcing, investing, value-enhancement, technical and capital markets experience. We believe that our management team is equipped with the knowledge, experience, capital and human resources, and corporate governance practices to pursue opportunities that will offer risk-adjusted returns.
more less
IPO Data
IPO File Date 02/19/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/14/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Tiger Brokers
EF Hutton
more
Company Data
Headquarters New York, NY, United States
Founded 2021
Employees 3

Estrella Biopharma (TradeUP Acquisition) (ESLA) Performance